Thiopental Panpharma 0,5 g Pulver till injektionsvätska, lösning

Maa: Ruotsi

Kieli: ruotsi

Lähde: Läkemedelsverket (Medical Products Agency)

Lataa Pakkausseloste (PIL)
21-02-2023

Aktiivinen ainesosa:

tiopentalnatrium

Saatavilla:

Panpharma

ATC-koodi:

N01AF03

INN (Kansainvälinen yleisnimi):

sodium thiopental

Annos:

0,5 g

Lääkemuoto:

Pulver till injektionsvätska, lösning

Koostumus:

tiopentalnatrium 500 mg Aktiv substans

Prescription tyyppi:

Receptbelagt

Tuoteyhteenveto:

Förpacknings: Injektionsflaska, 1 x 1 st (0,5 g); Injektionsflaska, 10 x 1 st (0,5 g); Injektionsflaska, 25 x 1 st (0,5 g); Injektionsflaska, 50 x 1 st (0,5 g)

Valtuutuksen tilan:

Godkänd

Valtuutus päivämäärä:

2022-06-02

Pakkausseloste

                                1
B. PACKAGE LEAFLET
2
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
THIOPENTAL
PANPHARMA
0,5 G POWDER FOR SOLUTION FOR INJECTION
THIOPENTAL PANPHARMA 1 G POWDER FOR SOLUTION FOR INJECTION
thiopental sodium
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor, pharmacist or
nurse.
-
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Thiopental Panpharma is and what it is used for
2.
What you need to know before you are given Thiopental Panpharma
3.
How Thiopental Panpharma is given
4.
Possible side effects
5.
How to store Thiopental Panpharma
6.
Contents of the pack and other information
1.
WHAT THIOPENTAL PANPHARMA IS AND WHAT IT IS USED FOR
This medicine contains the active substance thiopental sodium. It is a
thiobarbiturate with rapid onset
for intravenous administration (into the vein).
Thiopental Panpharma is used:
•
to start general anaesthesia (a state of heavy sleep e.g. during
surgery)
•
to provide hypnosis (you are sleepy but not completely asleep) during
anaesthesia together
with other anaesthetic agents
•
as part of treatment for cramps (including those caused by local
anaesthetics)
•
to reduce pressure in the skull (intracranial pressure) in patients
where the pressure is
increased (if controlled ventilation is provided)
2.
WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN THIOPENTAL PANPHARMA
YOU SHOULD NOT BE GIVEN THIOPENTAL PANPHARMA:
-
if you are allergic to thiopental, barbiturates or any of the other
ingredients of this medicine
(listed in section 6);
-
if you have an obstruction of the airways (respiratory obstruction);
-
if you have acute asthma (severe asthma attack);
-
if you suffer from hereditary muscle degeneration (myotonic
dystrophy);
-
if you are in severe shock;
-
if you have p
                                
                                Lue koko asiakirja
                                
                            

Asiakirjat muilla kielillä

Pakkausseloste Pakkausseloste englanti 21-02-2023
Valmisteyhteenveto Valmisteyhteenveto englanti 21-02-2023
Julkisesta arviointikertomuksesta Julkisesta arviointikertomuksesta englanti 20-05-2022